These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6723122)

  • 1. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.
    Yu TF; Roboz J; Johnson S; Kaung C
    J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine metal chelates and their possible importance in rheumatoid arthritis--a brief review.
    Davis P
    Clin Invest Med; 1984; 7(1):41-4. PubMed ID: 6723123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels and side-effects of D-penicillamine.
    Van Der Korst JK; Muijsers AO; Henrichs AM; Ament HJ; Van De Stadt RJ
    Agents Actions Suppl; 1979; (5):159-67. PubMed ID: 294133
    [No Abstract]   [Full Text] [Related]  

  • 9. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions of penicillamine in rheumatoid arthritis.
    Seideman P; Lindström B
    J Rheumatol; 1989 Apr; 16(4):473-4. PubMed ID: 2664169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with penicillamine in the treatment of cystinuria.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():100-2. PubMed ID: 6939870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of D-penicillamine in man.
    Wiesner RH; Dickson ER; Carlson GL; McPhaul LW; Go VL
    J Rheumatol Suppl; 1981; 7():51-5. PubMed ID: 6939886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of patients with rheumatoid arthritis in longterm administration of D-penicillamine.
    Dominkus M; Chlud K; Maida EM; Grisold W
    J Rheumatol; 1992 Oct; 19(10):1648-50. PubMed ID: 1464886
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of assay methods for D-penicillamine.
    Kucharczyk N; Shahinian S
    J Rheumatol Suppl; 1981; 7():28-34. PubMed ID: 6939884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
    Joyce DA; Day RO
    Br J Clin Pharmacol; 1990 Oct; 30(4):511-7. PubMed ID: 2291865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of factors limiting the accurate measurement of plasma D-penicillamine in rheumatoid arthritis patients.
    Webb BA; Richardson SJ; Haslock I
    Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():186-91. PubMed ID: 3382150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.